The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index; 15 of the 70 sources its claims cite were checked for support.
Semi-automated fact-checking of nucleotide sequence reagents in biomedical research publications: The Seek & Blastn tool
Open accessAbstract
Nucleotide sequence reagents are verifiable experimental reagents in biomedical publications, because their sequence identities can be independently verified and compared with associated text descriptors. We have previously reported that incorrectly identified nucleotide sequence reagents are characteristic of highly similar human gene knockdown studies, some of which have been retracted from the literature on account of possible research fraud. Because of the throughput limitations of manual verification of nucleotide sequences, we developed a semi-automated fact checking tool, Seek & Blastn, to verify the targeting or non-targeting status of published nucleotide sequence reagents. From previously described and unknown corpora of 48 and 155 publications, respectively, Seek & Blastn correctly extracted 304/342 (88.9%) and 1066/1522 (70.0%) nucleotide sequences and a predicted targeting/ non-targeting status. Seek & Blastn correctly predicted the targeting/ non-targeting status of 293/304 (96.4%) and 988/1066 (92.7%) of the correctly extracted nucleotide sequences. A total of 38/39 (97.4%) or 31/79 (39.2%) Seek & Blastn predictions of incorrect nucleotide sequence reagent use were correct in the two literature corpora. Combined Seek & Blastn and manual analyses identified a list of 91 misidentified nucleotide sequence reagents, which could be built upon through future studies. In summary, incorrect nucleotide sequence reagents represent an under-recognized source of error within the biomedical literature, and fact checking tools such as Seek & Blastn may help to identify papers and manuscripts affected by these errors.
Overview
CoChat Summary
TL;DR
Seek & Blastn (S&B) is a semi-automated fact-checking tool that extracts nucleotide sequences and their claimed targeting/non-targeting status from biomedical PDFs, then uses blastn to verify whether the claim matches the sequence identity. Applied to two corpora, it performed well on a known problematic corpus but less precisely on a broader unknown corpus, identifying 91 misidentified nucleotide sequence reagents overall.
Key findings
- S&B correctly extracted 304/342 (88.9%) nucleotide sequences and their targeting/non-targeting status from Corpus P and 1066/1522 (70.0%) from Corpus U.
- Among correctly extracted sequences, S&B correctly predicted targeting/non-targeting status for 293/304 (96.4%) in Corpus P and 988/1066 (92.7%) in Corpus U.
- S&B predictions of incorrect nucleotide sequence reagent use were correct for 38/39 (97.4%) Corpus P predictions and 31/79 (39.2%) Corpus U predictions.
- Combined S&B and manual analyses identified 91 misidentified nucleotide sequence reagents: 26 (28.6%) incorrectly identified sh/siRNA targeting reagents and 65 (71.4%) incorrectly identified PCR primers, including one mutagenesis primer; 48/91 (52.7%) had incorrect targeting/non-targeting status and 43/91 (47.3%) targeted a gene or sequence other than described.
Methods
- The authors developed S&B to extract nucleotide sequences and associated targeting/non-targeting claims from PDF text, perform blastn analyses against human genomic and transcript databases, and fact-check whether the claimed status matches the blastn result.
- S&B was tested on Corpus P (48 publications previously reported by Byrne and Labbé, containing 342 sequences) and Corpus U (155 publications containing nucleotide sequences, with 1522 sequences; retrieved via PubMed similar and Google Scholar queries, excluding papers already manually analyzed).
- Manual sequence extraction and independent blastn analyses cross-checked S&B predictions at the sequence and publication levels; Fisher’s exact test was used for specified proportion comparisons.
Limitations
- The paper states that S&B was applied to only selected text corpora and an overall small number of papers, that Corpus U retrieval means reported error frequencies are unlikely to represent the total journal literature, and that S&B has not yet been applied to consecutively published or randomly sampled corpora.
- The paper states that S&B was optimized on Corpus P, and its Corpus U error rate for sequence/status extraction was 30.0% versus 11.1% for Corpus P, with reduced precision of 39.2%; false positives included non-human sequences, incorrectly assigned targeting/non-targeting claims, and other issues.
- The paper notes that statistical comparisons used non-random, non-independent samples, so confidence intervals may be biased upwards; the text also makes evident that S&B cannot automatically flag targeting sequences that target different genes from those claimed, and that manual analysis remains necessary for some error types.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig 2 Example of Seek & Blastn (S&B) output for a retracted Corpus P paper (Ref. [22]). Columns shown from left to right are: “Tested file”; “Nearest dist”, which provides intertextual distance analysis results [9]; “Genes”, which provides gene and species identifiers extracted from the text; “Cont. CL”, which provides identifiers that correspond to contaminated or misidentified cell lines; and “Sequences”, which lists all nucleotide sequences that were extracted, and their corresponding blastn results. The tested publication forms part of the reference cohort [16], and its closest match is the same publication within the reference cohort. The tested pdf included 6 nucleotide sequences, which were correctly extracted and identified by S&B. Two extracted sequences were recognized as a previously reported sequence (SeqA) [16], and a mismatch was detected between the claimed non-targeting status and the blastn identity, as shown in red hypertext.](https://figures.cochat.ai/paper-figures/9293f9968bfd41b2ab98e1dc8af719f9/semi-automated-fact-checking-of-nucleotide-sequence-reagents-in-biomedical-figure-2.jpg)



Verification
Claims the paper makes
11 Valid · 1 Not valid · 26 Not checked · 86 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Gene knockdown and PCR techniques rely upon the correct design and experimental use of RNA targeting reagents and PCR primers, respectively [17–19].”
§ Semi-automated fact-checking of nucleotide sequence reagents in biomedical research publications: The Seek & Blastn tool > Introduction
What the sources say
- Not checked — no full text of the sourcecites [17] SC Taylor, 2014, The state of RT-quantitative PCR: firsthand observations of implementation of minimum information for the publication of quantitative real-time PCR experiments (MIQE), Mol Microbiol Biotechnol source
- Partly supportedcites [18] SA Bustin, 2009, The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments, Clin Chem sourceExperimental — accuracy not yet measured
Section 7.2 (Specificity) supports the PCR-primer part: it says primer specificity must be validated experimentally and poor annealing optimization affects assay quality. The citation is attached to a sentence that also concerns RNA-targeting reagents for gene knockdown, which the cited passages do not address. (LLM, conf=0.85)
- Supportedcites [19] CB Moore, 2010, Short hairpin RNA (shRNA): design, delivery, and assessment of gene knockdown, Methods Mol Biol source
The Introduction calls target-sequence selection a critical component of successful gene knockdown. Methods §3.1 gives procedures for selecting shRNAs and controls, while Methods §3.5 specifies how to design and use primers for quantitative PCR. Together, these passages support the attributed statement. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
““Typographic” errors typically produce less efficient reagents, by reducing the reagent’s ability to bind its genetic target [17, 20, 21], whereas wrongly identified reagents could bind unexpected targets and produce irrelevant results [16].”
§ Semi-automated fact-checking of nucleotide sequence reagents in biomedical research publications: The Seek & Blastn tool > Introduction
What the sources say
- Not checked — no full text of the sourcecites [17] SC Taylor, 2014, The state of RT-quantitative PCR: firsthand observations of implementation of minimum information for the publication of quantitative real-time PCR experiments (MIQE), Mol Microbiol Biotechnol source
- Partly supportedcites [20] W Habbal, 2005, Errors in published sequences of human cytomegalovirus primers and probes: do we need more quality control?, J Clin Microbiol sourceExperimental — accuracy not yet measured
In the main text, the paper says mismatches at the 3′ ends of two CMV primers may reduce PCR efficiency and mismatches in two probes may drastically affect their efficacy. It does not establish that typographic errors typically make reagents less efficient, or directly show reduced binding to genetic targets. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [21] R Stadhouders, 2010, The effect of primer-template mismatches on the detection and quantification of nucleic acids using the 5' nuclease assay, J Mol Diagn source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In the field of biomedical research, the majority of incorrect results are estimated to derive from the incorrect use of material standards and experimental reagents [2, 3].”
§ Semi-automated fact-checking of nucleotide sequence reagents in biomedical research publications: The Seek & Blastn tool > Introduction
What the sources say
- Could not verifycites [2] J Stebbing, 2018, The importance of being earnest in post-publication review: scientific fraud and the scourges of anonymity and excuses, Oncogene sourceExperimental — accuracy not yet measured
The paper’s discussion of publication misconduct and image duplication (pp. 695–696) does not estimate the causes of incorrect biomedical results. Searches for material standards, experimental reagents, and the claimed majority estimate found no passage addressing them. (LLM, conf=0.76)
- Partly supportedcites [3] LP Freedman, 2015, The economics of reproducibility in preclinical research, PLoS Biol sourceExperimental — accuracy not yet measured
The ‘Analysis of Four Categories of Irreproducibility’ section identifies biological reagents and reference materials as one cause of irreproducible preclinical research. But ‘The Role of Best Practices and Standards’ says that study-design errors and reagent/material errors together account for a majority of estimated spending on irreproducible research; it does not say reagent and material errors alone cause the majority of incorrect results. (LLM, conf=0.87)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The equivalent of spelling mistakes (nucleotide substitutions, deletions or insertions) can be accidentally introduced into nucleotide sequences [17, 20], errors that we will describe as “typographic”.”
§ Semi-automated fact-checking of nucleotide sequence reagents in biomedical research publications: The Seek & Blastn tool > Introduction
What the sources say
- Not checked — no full text of the sourcecites [17] SC Taylor, 2014, The state of RT-quantitative PCR: firsthand observations of implementation of minimum information for the publication of quantitative real-time PCR experiments (MIQE), Mol Microbiol Biotechnol source
- Supportedcites [20] W Habbal, 2005, Errors in published sequences of human cytomegalovirus primers and probes: do we need more quality control?, J Clin Microbiol source
Table 1 identifies missing, added and exchanged nucleotides in published CMV oligonucleotide sequences. The paper also says several sequences were incorrectly transferred from earlier publications, supporting the claim that such errors can be introduced accidentally. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The S&B tool therefore directly addresses the larger problem of material reagents and standards representing the major source of incorrect published results from pre-clinical research [3, 4].”
§ Semi-automated fact-checking of nucleotide sequence reagents in biomedical research publications: The Seek & Blastn tool > Discussion
What the sources say
- Partly supportedcites [3] LP Freedman, 2015, The economics of reproducibility in preclinical research, PLoS Biol sourceExperimental — accuracy not yet measured
The Analysis of Four Categories of Irreproducibility identifies biological reagents and reference materials as one of four primary causes of irreproducibility. The Role of Best Practices and Standards says that errors in study design and biological reagents and materials *together* account for a majority of the estimated burden; it does not establish reagents and standards alone as the major source of incorrect published results. The statement about what the S&B tool addresses is the citing authors’ inference, not a finding attributed to this paper. (LLM, conf=0.86)
- Partly supportedcites [4] LP Freedman, 2017, Reproducibility2020: Progress and priorities, F1000Res sourceExperimental — accuracy not yet measured
The Introduction’s “Irreproducibility: Drivers and impact” section identifies reagent and material variability as sources of experimental variation. Section II, “Reagents and reference materials,” says standards can help address reproducibility problems, but it does not establish that reagents and standards are the major source of incorrect published preclinical results. The paper also does not evaluate the S&B tool. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
65 more claims · 1 with their cited sources checked
Create a free account to see all 124 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 35
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas 31/75 (41%) problematic SGK articles have been reported in earlier studies (12, 13), the remaining 45 SGK articles have not been previously analysed (Table 2).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Most (67/115, 58%) incorrect sequences recurred across at least two SGK articles (Fig 3 and Table S1), where the most frequent incorrect reagent was a previously described “non-targeting” shRNA that is predicted to target TPD52L2 (11, 12, 13).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SGK articles showed numerous unexpected similarities, such as similarities in textual and figure organisation, outlier levels of textual similarity, and the description of identical incorrect sequence reagents across articles that investigated different genes (11, 12, 13).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nonetheless, the selection of Gene and Oncology Reports as representative examples of journals known to have published articles with wrongly identified sequences (11, 12, 13) may have increased the likelihood of identifying problematic articles from China which were also affiliated with hospitals.”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gene and Oncology Reports were selected for S&B screening as representative examples of journals that have published articles with incorrect nucleotide sequences (11, 12, 13), where Oncology Reports also published the highest number of problematic SGK articles (Supplemental Data 6).”
From Identification of human gene research articles with wrongly identified nucleotide sequences (2022) · cites this paper as [12]
Experimental — accuracy not yet measured
17 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
Cited work 10.1111/cbdd.12428 · retracted 2018-10-30 · notice 10.1111/cbdd.13422 · this paper published 2019-03-01
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
Cited work 10.4048/jbc.2015.18.3.218 · retracted 2018-03-23 · notice 10.4048/jbc.2018.21.1.102 · this paper published 2019-03-01
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
Cited work 10.1155/2016/5230642 · retracted 2017-08-28 · notice 10.1155/2017/7640820 · this paper published 2019-03-01
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
Cited work 10.1111/cbdd.12573 · retracted 2018-08-16 · notice 10.1111/cbdd.13339 · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“2017, Retraction: SUN1 silencing inhibits cell growth through G0/G1 phase arrest in lung adenocarcinoma, Onco Targets Ther, 10, 5935, 10.2147/OTT.S159520”
Cited work 10.2147/ott.s159520 · retraction date not known · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“2017, Retraction of: Tumor Protein D52-Like 2 Contributes to Proliferation of Breast Cancer Cells; 10.1089/cbr.2014.1723, Cancer Biother Radiopharm, 32, 387, 10.1089/cbr.2014.1723.retract”
Cited work 10.1089/cbr.2014.1723.retract · retraction date not known · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Retraction. Down-regulation of GPR137 expression inhibits proliferation of colon cancer cells. Acta Biochim Biophys Sin. 10.1093/abbs/gmy057 29726888”
Cited work 10.1093/abbs/gmy057 · retraction date not known · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“2016, Retracted: Knockdown of tumor protein D52-like 2 induces cell growth inhibition and apoptosis in oral squamous cell carcinoma, Cell Biol Int, 40, 361, 10.1002/cbin.10593”
Cited work 10.1002/cbin.10593 · retraction date not known · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“2017, Retraction of: Tumor Protein D52-Like 2 Accelerates Gastric Cancer Cell Proliferation; 10.1089/cbr.2014.1766, Cancer Biother Radiopharm, 32, 388, 10.1089/cbr.2014.1766.retract”
Cited work 10.1089/cbr.2014.1766.retract · retraction date not known · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.7314/apjcp.2012.13.3.1043 · retraction date not known · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work W2415745096 · retraction date not known · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Retracted: Long Noncoding RNA KIAA0125 Potentiates Cell Migration and Invasion in Gallbladder Cancer. Biomed Res Int. 2017; 2017: 3471417 10.1155/2017/3471417 28929110 PMC5591979”
Cited work 10.1155/2017/3471417 · retraction date not known · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Retraction. Long Non-coding RNA Linc-ITGB1 Knockdown Inhibits Cell Migration and Invasion in GBC-SD/M and GBC-SD Gallbladder Cancer Cell Lines. Chem Biol Drug Des. 2018; 92: 1815 10.1111/cbdd.13339 25893892”
Cited work 10.1111/cbdd.13339 · retraction date not known · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“2018, Retraction note to: Lentivirus-Mediated Short-Hairpin RNA Targeting Protein Phosphatase 4 Regulatory Subunit 1 Inhibits Growth in Breast Cancer, J Breast Cancer, 21, 102, 10.4048/jbc.2018.21.1.102”
Cited work 10.4048/jbc.2018.21.1.102 · retraction date not known · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“2017, Retraction notice to: Myosin VI contributes to malignant proliferation of human glioma cells, Korean J Physiol Pharmacol, 21, 565, 10.4196/kjpp.2017.21.5.565”
Cited work 10.4196/kjpp.2017.21.5.565 · retraction date not known · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Retraction. si-RNA-Mediated Knockdown of PDLIM5 Suppresses Gastric Cancer Cell Proliferation in Vitro. Chem Biol Drug Des. 2018; 92: 2035 10.1111/cbdd.13422 25215606”
Cited work 10.1111/cbdd.13422 · retraction date not known · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Retracted: Silencing of the COPS3 Gene by siRNA Reduces Proliferation of Lung Cancer Cells Most Likely via Induction of Cell Cycle Arrest and Apoptosis. Asian Pac J Cancer Prev. 2017; 18: 2893 29148631 PMC5747420”
Cited work 10.22034/apjcp.2017.18.10.2893 · retraction date not known · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Retracted: siRNA Mediated Silencing of NIN1/RPN12 Binding Protein 1 Homolog Inhibits Proliferation and Growth of Breast Cancer Cells. Asian Pac J Cancer Prev. 2017; 18: 2891 10.22034/APJCP.2017.18.10.2891 29127950 PMC5747419”
Cited work 10.22034/apjcp.2017.18.10.2891 · retraction date not known · this paper published 2019-03-01
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Retracted: High Expression of PTGR1 Promotes NSCLC Cell Growth via Positive Regulation of Cyclin-Dependent Protein Kinase Complex. Biomed Res Int. 2017; 2017: 7640820 10.1155/2017/7640820 28932745 PMC5592405”
Cited work 10.1155/2017/7640820 · retraction date not known · this paper published 2019-03-01
Citations
Cites
19 retracted
Wang, L., Zhang, Y., Lv, W., Lu, J., Mu, J., Liu, Y., & Dong, P. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12573 · Cited by 21
RetractedHuang, W., Chen, D., Li, N., & Wang, L. (2017) · PubMed Central · doi:10.22034/apjcp.2017.18.10.2891 · Cited by 20
RetractedLi, Y.-L., Gao, Y., Xu, Y., Sun, X., Song, X., Ma, H., & Yang, M. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12428 · Cited by 17
RetractedHuang, X., Zhou, W., Zhang, Y., & Liu, Y. (2016) · BioMed Research International · doi:10.1155/2016/5230642 · Cited by 14
RetractedLentivirus-mediated TPD52L2 depletion inhibits the proliferation of liver cancer cells in vitro.
Pan, Z., Yang, Y., Pān, H., Zhang, J., Liu, H., Yang, Y., Huang, G., Yin, L., Huang, J., & Zhou, W. (2015) · PubMed · Cited by 13
RetractedWang, X., Cui, J., Li, W., Cai, L., Song, W., & Wang, G. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.3.1043 · Cited by 12
RetractedHe, Y., Chen, F., Cai, Y., & Chen, S. (2016) · Cell Biology International · doi:10.1002/cbin.10593 · Cited by 8
RetractedQi, Y., Hu, T., Li, K., Ye, R., & Ye, Z. (2015) · Journal of Breast Cancer · doi:10.4048/jbc.2015.18.3.218 · Cited by 6
RetractedRetraction – Down-regulation of GPR137 expression inhibits proliferation of colon cancer cells
Zhang, K., Shen, Z., Liang, X., Liu, T., Wang, T., & Jiang, Y. Z. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy057 · Cited by 4
RetractedRetracted: Long Noncoding RNA KIAA0125 Potentiates Cell Migration and Invasion in Gallbladder Cancer
International, B. R. (2017) · BioMed Research International · doi:10.1155/2017/3471417 · Cited by 3
Retracted
Research works printed but not linked: 1
- 2018, Retraction. TPD52L2 silencing inhibits lung cancer cell proliferation by G2/M phase arrest, Int J Clin Exp Med, 11, 413
Cited by
Byrne, J. A., & Christopher, J. (2020) · FEBS Letters · doi:10.1002/1873-3468.13747 · Cited by 133
Self-citationIs the future of peer review automated?
Schulz, R., Barnett, A., Bernard, R., Brown, N. J. L., Byrne, J. A., Eckmann, P., Gazda, M. A., Kilicoglu, H., Prager, E. M., Salholz-Hillel, M., et al. (2022) · BMC Research Notes · doi:10.1186/s13104-022-06080-6 · Cited by 80
“…compliance and research and reporting quality assessments provide authors with valuable feedback, while all three Seek and blastn (semi‑automated) [23] Confirms that nucleotide sequences were correctly identified: Incorrect identification or use of nucleotide sequences makes it difficult to…”
BackgroundSelf-citationPaper mill challenges: past, present, and future
Parker, L., Boughton, S., Bero, L., & Byrne, J. A. (2024) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2024.111549 · Cited by 81
Self-citationReasons for and time to retraction of genetics articles published between 1970 and 2018
Dal‐Ré, R., & Ayuso, C. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106137 · Cited by 78
Weissgerber, T., Riedel, N., Kilicoglu, H., Labbé, C., Eckmann, P., ter Riet, G., Byrne, J., Cabanac, G., Capes-Davis, A., Favier, B., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-01203-7 · Cited by 57
Self-citation
Metadata
- Authors
- Labbé, C., Grima, N., Gautier, T., Favier, B., & Byrne, J. A.
- Affiliations
- Institut polytechnique de Grenoble (FR)
- Children's Hospital at Westmead (AU)
- Centre National de la Recherche Scientifique (FR)
- Établissement Français du Sang (FR)
- The University of Sydney (AU)
- Corresponding author
- Labbé, Cyril
- Byrne, Jennifer A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-03-01
- Volume
- 14
- Issue
- 3
- Pages
- e0213266
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6396917
- OpenAlex
- W2918695271
- Cited by
- 55
- References
- 70
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 6 · 2023: 2 · 2022: 6 · 2021: 20 · 2020: 15 · 2019: 1
- FWCI
- 18.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- University of Sydney (Post-Truth Initiative, a Sydney University Research Excellence Initiative (SREI 2020))
- US Office of Research Integrity (ORIIR180038-01-00)
- Topics
- Social Sciences › Education › Academic integrity and plagiarism
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Keywords
- fact-checking, research integrity, gene knockdown, scientific fraud, BLASTN
- MeSH terms
- Algorithms, Humans, Indicators and Reagents, Publications, Sequence Alignment, Sequence Analysis, DNA, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-01, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-01 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Semi-automated fact-checking of nucleotide sequence reagents in biomedical research publications: The Seek & Blastn tool. https://app.cochat.ai/papers/10.1371/journal.pone.0213266
- The paper
- Labbé, C., Grima, N., Gautier, T., Favier, B., & Byrne, J. A. (2019). Semi-automated fact-checking of nucleotide sequence reagents in biomedical research publications: The Seek & Blastn tool. PLOS ONE. https://doi.org/10.1371/journal.pone.0213266
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.